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Feeding a modified fish diet has been suggested to improve insulin sensitivity in bottlenose 
dolphins; however, insulin sensitivity was not directly measured. Since demonstrating an 
improvement in insulin sensitivity is technically difficult in dolphins, we postulated that directional 
changes in the hormone axis: fibroblast growth factor 21 (FGF21)/Adiponectin/Ceramide 
(Cer), could provide further support to this hypothesis. We measured 2-h post-prandial serum 
FGF21, total adiponectin, percent unmodified adiponectin, ceramide, and sphingosine levels 
from dolphins fed a diet rich in heptadecanoic acid (C17:0) over 24 weeks. Serum FGF21 
was quantified by ELISA with an observed range of 129–1599 pg/ml, but did not significantly 
change over the 24-week study period. Total adiponectin levels (mean ± SD) significantly 
increased from 776 ± 400 pmol/ml at week 0 to 1196 ± 467 pmol/ml at week 24. The per-
cent unmodified adiponectin levels (mean ± SD) decreased from 23.8 ± 6.0% at week 0 to  
15.2 ± 5.2% at week 24. Interestingly, although FGF21 levels did not change, there was a 
good correlation between FGF21 and total adiponectin (ρ = 0.788, P < 0.001). We quantified 
the abundances of serum ceramides and sphingosines (SPH) because adiponectin has a 
defined role in sphingolipid metabolism through adiponectin receptor-mediated activation of 
ceramidases. The most abundant ceramide in dolphin sera was Cer 24:1 comprising 49% of 
the ceramides measured. Significant reductions were observed in the unsaturated Cer 18:1, 
Cer 20:1, and Cer 24:1, whereas significant increases were observed in saturated Cer 22:0, 
Cer 24:0, and Cer 26:0. However, total serum ceramides did not change. Significant eleva-
tions were detected for total sphingosine, dihydrosphingosine, sphingosine-1-phosphate, 
and dihydrosphingosine-1-phosphate. Proteomic analysis of the serum proteins revealed 
few changes in serum proteins over the study period. In conclusion, shifting the dolphin diet 
to fishes rich in odd chain saturated fatty acids, such as C17:0, resulted in increased serum 
levels of the insulin sensitizing hormone adiponectin and serum SPH consistent with an 
insulin-sensitizing phenotype. It is still unclear whether FGF21 plays a role in the regulation of 
adiponectin in dolphins, similar to that shown in laboratory animal models.
Keywords: parallel reaction monitoring mass spectrometry, FgF21, sphingosine-1-phosphate, insulin sensitivity, 
c17:0, proteomics, metabolic syndrome, ceramides
Abbreviations: Cer, ceramide; dS1P, dihydro-sphingosine-1-phosphates; dSPH, dihydro-sphingosines; FGF21, fibroblast 
growth factor 21; HMW, high molecular weight; S1P, sphingosine-1-phosphates; SPH, sphingosines.
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inTrODUcTiOn
Dolphins can develop a condition similar to humans with meta-
bolic syndrome that includes elevated serum insulin, glucose, 
triglycerides, cholesterol, iron, saturated transferrin, ferritin, and 
total iron, with associated steatosis and iron overload (1–3). A 
study investigating differences in serum lipid profiles between 
two groups of dolphins, with high or low insulin, found dif-
ferences in phospholipid fatty acids that may play a role in the 
susceptibility to or development of an insulin-resistant-like state 
(3). Higher blood levels of the fatty acids C17:0 (heptadecanoic 
acid), C20:4n6 (arachidonic acid), and C22:0 (behenic acid), in 
particular, were associated with lower insulin levels. A recently 
published 24-week pilot study investigated the effect of modify-
ing the diet with species of fish that are rich in C17:0 (pinfish and 
mullet) in six dolphins. The investigators reported an elevation 
in serum C17:0 over the course of the study that was correlated 
with a significant reduction in serum ferritin levels. Furthermore, 
a marked reduction in post-prandial variability was noted for 
serum insulin, triglycerides, and glucose concentrations (3). 
This “correction” was interpreted as a possible increase in insulin 
sensitivity. Insulin sensitivity as determine by HOMA-IR scoring 
has not been developed for dolphins and the use of a hyperinsu-
linemic–euglycemic clamp to define insulin resistance in these 
animals is very invasive and not reasonable given the protections 
afforded these animals. Therefore, we postulated that directional 
changes in other hormone systems, known to improve insulin 
sensitivity, should also change in a direction that supports the 
hypothesis of improving insulin sensitivity in this small pilot 
cohort.
Insulin sensitivity is controlled through a complex interaction 
of multiple hormones and target tissues (4). One of the more 
prominent systems is the fibroblast growth factor 21 (FGF21)/
Adiponectin/Ceramide axis (5). FGF21 is a potent regulator of 
metabolism and energy utilization by exerting its glycemic and 
insulin-sensitizing effects through the upregulation of adiponec-
tin secretion (5). Adiponectin is an adipokine that forms oligom-
ers and circulates as trimers, hexamers, and high molecular 
weight (HMW) forms (6). The relevant action of each oligomer 
is tissue specific, with the HMW form known to exert a greater 
response on hepatocytes, thereby modulating gluconeogenesis, 
lipolysis, and insulin sensitivity (7, 8). Increased adiponectin 
levels have been associated with better glycemic control and lipid 
profiles in humans with type 2 diabetes (9, 10). In healthy labora-
tory animals, adiponectin signaling increases ceramidase activity 
that converts ceramides into sphingosines (SPH) (11). Ceramides 
are lipid metabolites that promote apoptosis, inflammation, 
and insulin resistance, whereas SPH promote cell survival and 
anti-inflammatory actions (12). Imbalance in the ceramide and 
sphingosine rheostat has been associated with obesity and insulin 
resistance (13, 14).
The HMW adiponectin protein forms as a result of glyco-
sylation of lysine residues in its collagenous domain (15). The 
concentration of HMW adiponectin, and not total adiponectin 
levels, has been shown to improve insulin sensitivity (16). Our 
previous work validated a parallel reaction monitoring mass 
spectrometry (PRM-MS) assay for dolphin total adiponectin and 
described a second fractional peptide measurement at lysine 75 
(% unmodified) whose presence implicated this measurement 
as a proxy of HMW adiponectin (17). The proportion of this 
unmodified at lysine 75 peptide to total adiponectin was able 
to differentiate between dolphins with hemochromatosis and 
elevated post-prandial insulin levels versus healthy dolphins (17).
For the dolphins in the 24-week pilot study (3), we hypoth-
esized that these animals (1) will have an intact FGF21/
Adiponectin/Ceramide axis similar to other mammals and (2) 
will increase in serum FGF21, adiponectin, and sphingosine 
and will decrease in serum percent unmodified adiponectin and 
ceramides in response to the modified fish diet in dolphins. To 
test our hypothesis, we quantified the serum levels of FGF21, 
adiponectin, percent unmodified adiponectin, ceramides, and 
SPH in the same six bottlenose dolphins on a modified diet as 
reported in Venn-Watson et al. (3). Furthermore, we investigated 
whether these measurements correlated with blood labora-
tory measurements used to characterize metabolic syndrome. 
Information-dependent acquisition-based LC-MS/MS proteom-
ics was also used to investigate changes in non-target, highly 
abundant, serum proteins.
MaTerials anD MeThODs
study Population
The bottlenose dolphin (Tursiops truncatus) modified diet study 
population was utilized in this study and has been previously 
described (3). The study was conducted under the Marine 
Mammal Program (MMP) IACUC-approved animal care and use 
protocol #101–2012. Animals E, W, and Q were females ages 12, 
51, and 32 years, respectively. Animals V, A, and BB were males 
ages 42, 35, and 8  years, respectively. Briefly, six dolphins had 
a baseline diet of 70–80% capelin and 20–30% mix of herring, 
mackerel, and/or squid that was modified to 25% capelin, 25% 
mullet, and/or pinfish, and 50% mix of herring, mackerel, and/
or squid. Total daily kilocalories remained the same. The modi-
fied diet resulted in significantly increased daily intake of C17:0. 
Proximate analyses for fish nutrients (kilocalories, % moisture, % 
protein, % fat, % ash, and % carbohydrates) are routinely meas-
ured by Michelson Laboratories, Inc. (Commerce, CA, USA) for 
every fish lot that is part of Navy marine mammal diets. Thus, 
nutrient data for the baseline and modified diets for our study 
were available and can be found in Table S1 in Supplementary 
Material. Daily dietary kilocalories were calculated per kilogram 
of body weight for each dolphin. Daily moisture, protein, fat, ash, 
and carbohydrate intake was calculated as total grams ingested per 
kilogram of body weight for each dolphin. Daily nutrient intake 
was then compared between baseline and modified diets using a 
Wilcoxon two-sample test. There were no significant differences 
in total daily dietary kilocalories, moisture, protein, fat, ash, or 
carbohydrate when comparing baseline and modified diets.
samples
Aliquots of dolphin serum were shipped overnight on dry ice from 
the feeding study population of six bottlenose dolphins in the 
U.S. Navy Marine Mammal Program, as previously reported (3). 
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Upon arrival, the samples were flash thawed in a 40°C water bath 
for 2 min, vortexed for 10 s, and centrifuged at 3000 × g for 10 s 
in a tabletop centrifuge before being aliquoted into 110 and 50 μl 
aliquots that were then frozen at −80°C until tested.
Fibroblast growth Factor 21
Serum FGF21 concentrations were determined using the Fibroblast 
Growth Factor 21 Mouse/Rat ELISA kit (Biovendor, Asheville, 
NC, USA) guided by the manufacturer’s instructions. A detailed 
description can be found in Data Sheet 1 in the Supplemental 
Data section. Batch corrections were not applied as the inter-assay 
coefficient of variation for the mean of the reference material was 
0.23%. Intra-assay coefficient of variation was 8.2%.
ceramides
Serum aliquots (110 μl) were submitted to the MUSC Lipidomics 
Core for ceramide and sphingosine determination following the 
established protocol of Ref. (18). Briefly, serum was diluted in 
serum-free media and spiked with internal standard solutions 
to quantify the following: SPH, dihydro-sphingosines (dSPH), 
sphingosine-1-phosphates (S1P), dihydro-sphingosine-1-phos-
phates (dS1P), Ceramides (Cer 16:0, Cer 14:0, Cer 16:0, Cer 18:0, 
Cer 18:1, Cer 20:0, Cer 24:0, Cer 24:1, Cer 26:0, and Cer 26:1), 
and dihydro-ceramide (Cer d16:0). The ceramides quantified 
contained a d18:1 sphingoid backbone and the numbers refer to 
the number of carbons:number of double bonds in the N-linked 
fatty acid. Lipids were extracted using a solution of 30:10:60 
isopropanol:water:ethyl acetate. Samples were vortexed, and 
centrifuged at 4000 × g for 10 min. Supernatant was transferred 
to a new tube, formic acid was added, and the extraction process 
was repeated. Supernatants were then combined, evaporated, and 
reconstituted in mobile phase A (1 mM ammonium formate in 
methanol containing 0.2% formic acid). This was vortexed and 
centrifuged for 5 min at 4000 × g. Samples were analyzed on a 
triple quadrupole mass spectrometer equipped with electrospray 
ion source (Thermo Finnigan). Concentrations were determined 
by external standard curve. Any sample that did not exceed the 
concentration of the blank by a factor of two was considered below 
limit of detection. Data are reported as picomole per milliliter.
reagents, chemicals, and synthetic 
Peptide standards
Reagents used were ACS grade or better. Water, acetonitrile, and 
methanol were LC-MS grade (Honeywell Burdick & Jackson, 
Morristown, NJ, USA). Synthetic stable isotope-labeled peptides 
for adiponectin were previously described in detail (17) and were 
synthesized by New England Peptide (Gardner, MA, USA).
Preparation of Tryptic Peptides
The preparation of serum for analysis of adiponectin was per-
formed following an established protocol (17) with the follow-
ing modifications. An aliquot of dolphin serum was thawed at 
room temperature for 1 min, vortexed for 5 s, then diluted (1:10; 
v:v) in 50 mM ammonium bicarbonate (AmBic). A solution of 
dithiothreitol (dissolved in 25 mM AmBic) was mixed by pipet 
to a final concentration of 100 mM, then centrifuged briefly, and 
incubated at 60°C for 30 min. The reaction was allowed to cool for 
5 min, then alkylated by the addition of iodoacetamide (dissolved 
in 50 mM AmBic) to a final concentration of 10 mM, and incu-
bated at 37°C for 30 min. The reaction was diluted with 176.5 μl 
50 mM AmBic before adding mass spectrometry grade trypsin 
gold (Promega, Madison, WI, USA) at a 1:10 ratio of enzyme to 
protein. The reaction was incubated at 37°C for 16 h, then stopped 
by the addition of 350 μl of 1% formic acid, and incubated at room 
temperature for 30 min. The two isotopically labeled standards 
were added to each sample, completed to 1 ml with 0.1% formic 
acid, and then loaded the sample onto an acetonitrile conditioned 
Strata-X 33  μ polymeric reverse phase solid phase extraction 
column (Phenomenex, Torrance, CA, USA). The column was 
washed twice with 1 ml 0.1% formic acid. Peptides were eluted first 
with 1 ml of 15% acetonitrile/0.1% formic acid then in a separate 
tube with 1 ml 30% acetonitrile/0.1% formic acid. Eluted samples 
were frozen at −80°C overnight, then dried down under vacuum 
by speedvac. Each sample was resuspended in 100 μl MPA (98% 
water, 2% acetonitrile, 0.1% formic acid), vortexed for 15 min, 
then centrifuged at 10,000 × g for 5 min before being transferred 
to a new 1.5 ml microcentrifuge tube. Peptide concentration was 
estimated by absorbance at 280 nm (average ~14 μg/μl). Prior to 
injection, 5 μl of the sample was diluted into 195 μl of MPA, and 
then injected onto the trap column.
adiponectin Quantification
Peptides of total and Lys-75 unmodified adiponectin were quan-
tified using previously published protocols from Neely et al. (17) 
with the following modifications. Tryptic peptides (10 μl) were 
loaded onto a 100 μm × 2 cm C18 (100 Å with 5 μm particles) 
trap column (Acclaim PepMap® 100; Thermo Fisher Scientific) 
and separated on a 75 μm × 15 cm C18 (100 Å with 3 μm par-
ticles) analytical column (Acclaim PepMap100®; Thermo Fisher 
Scientific). Reverse phase separation occurred at 350 nl/min on a 
2D+ NanoLC Ultra system (Eksigent, Dublin, CA, USA). The LC 
was connected via nanospray source to a Triple-TOF 5600 mass 
spectrometer (AB Sciex, Foster City, CA, USA).
Dolphin sera were processed in randomized batches of 9. One 
serum in each batch was processed in triplicate to determine 
experimental variability. One serum in each batch was injected 
in triplicate to account for intra-batch variability. Each batch 
also contained a standard reference material (SRM) serum to 
correct between experimental batches, and an experimental 
blank consisting of phosphate-buffered saline (PBS). The blank 
was processed identically to serums in each batch and contained 
the same amount of trypsin as the SRM. For PRM experiments, 
the instrument was set in positive ion mode and TOF-MS 
data were collected in a window of 450–1250  m/z for 150  ms, 
followed by each parent ion MS/MS for 200  ms, from 100 to 
1600  m/z. Total dolphin adiponectin (IFY) was quantified by 
comparing the ratio between the native IFY y132+ product ion 
(586.93+ →  749.832+ m/z) and the corresponding product ion 
from the SIS peptide (589.63+ → 753.832+ m/z). The amount of 
Lys-75 unmodified (GDT) dolphin adiponectin was quantified 
by comparing the ratio between the native GDT y7+ product ion 
(716.342+ →  715.37+ m/z) and the corresponding product ion 
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from the standard peptide (721.342+ → 725.37+ m/z). The amount 
of percent unmodified was calculated as (GDT/IFY) × 100.
Proteomic analysis of serum
One microliter of dilute peptides (1:40; v/v, ~1 μg) was loaded 
onto the trap at 5 μl/min for 5 min before reverse phase separation 
at 350 nl/min from 0 to 40% mobile phase B (95% acetonitrile 
in 0.1% formic acid) over 50 min. Tryptic peptides were identi-
fied by performing runs in positive ion, information-dependent 
acquisition mode with product ion scans for 50 ms with up to 
20 product ion scans if precursors were 350–1250 m/z, exceeded 
100 cps, and had a 2+ to 5+ charge state (AnalystTF1.6). Raw 
data files generated by the AB Sciex 5600 were converted to a 
peak list using the AB Sciex MS Data Converter (v. 1.3. beta, June 
2012). Protein identifications were made using Mascot Daemon 
(v. 2.4.0) searching against the Ensembl (release 64) turTru1 
dolphin genome assembly protein database [16,599 sequences; 
Lindblad-Toh (19)] and the common Repository of Adventitious 
proteins database (cRAP; 2012.01.01; the Global Proteome 
Machine) using the following parameters: trypsin was selected 
as the enzyme and two missed cleavages were allowed; carba-
midomethylation (Cys) was specified as a fixed modification; 
Gln → pyro-Glu (N-term Q) and Oxidation (M) were specified as 
variable modifications; a peptide tolerance of 20 ppm and MS/MS 
tolerance of 0.1 Da; instrument type was set to ESI-QUAD-TOF. 
Mascot files were then uploaded into Scaffold Q+ (v.4.4.5) for 
analysis with a protein threshold set to 1.0% false discovery rate, 
a minimum number of peptides set to 3, and a peptide threshold 
set to 50%. Proteins were excluded from analysis that did not have 
a spectral count >10 in at least one time point, or were missing 
from two or more dolphin samples at a time point. The quanti-
tative value was normalized to total TIC with a normalization 
value set to 0. Values were imported into sigma plot 11.0 and 
log10 transformed to improve normality of the data. Proteomics 
data have been deposited to the ProteomeXchange Consortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE 
partner repository (20) with the dataset identifier PXD003425.
statistics
All statistical analyses were performed with SigmaPlot 11.0 (Systat 
Software). Pearson Product Moment Correlation analysis was 
performed to detect correlations between adiponectin, FGF21, 
ceramides, SPH, and previously measured serum components, 
i.e., insulin, glucose, tryglycerides, iron, transferrin saturation, 
ferritin, ceruloplasmin, and haptoglobin (3). Adiponectin, cera-
mide, and sphingosine time-series data were analyzed by one-
way ANOVA for repeated measures. For data that did not pass 
equal variance or normality tests, data were log transformed and 
the ANOVA was repeated. For the proteomics data, a repeated 
one-way ANOVA was performed on the log-transformed values 
that met the inclusion criteria. Post hoc comparisons versus time 
0 were made using the Holm–Sidak post  hoc test. Differences 
were considered statistically significant if P < 0.05. Fold change 
for each identified protein was calculated by dividing the mean 
quantitative value at a time point by the mean quantitative value 
at time 0.
resUlTs
Modified Diet is associated with increased 
levels of Total adiponectin and reduced 
levels of Percent Unmodified adiponectin
We measured the levels of total and percent unmodified adi-
ponectin (Figures  1A,B) in six dolphins on the modified diet 
(3). Adiponectin levels were within previously reported ranges 
(17). The mean levels of adiponectin (pmol/mL ±  SD) for the 
dolphins at 0-weeks was 776 ± 401; 3 weeks, 937 ± 531; 6 weeks, 
806 ±  382; 12  weeks, 1147 ±  477; 18  weeks, 1189 ±  640; and 
24 weeks, 1196 ± 467. The change in serum adiponectin levels 
were significantly elevated in the dolphins at weeks 12, 18, and 24 
(P < 0.002) compared to week 0 (Figure 1C). The mean levels of 
percent unmodified adiponectin (mean% unmodified ± SD) in 
the dolphins at week 0 was 23.8 ± 6; 3 weeks, 18.9 ± 6; 6 weeks, 
18.4 ±  6; 12  weeks, 18.0 ±  4; 18  weeks, 16.0 ±  4; 24  weeks, 
15.2 ± 5. The mean change in percent unmodified adiponectin 
was reduced (P < 0.03) at all collection intervals versus control 
at week 0 (Figure  1D). Only one dolphin contained serum 
FGF21 concentrations below the LLOQ. In the other five dolphin 
samples above the LLOQ, serum FGF21 concentrations ranged 
from 129 to 1599 pg/ml. The mean change in FGF21 levels was 
not significantly different over the course of the study (Figure 
S1 in Supplementary Material). Previously published serum 
insulin levels for each dolphin (3) are presented in Figure S2 in 
Supplementary Material.
associations of adiponectin with 
Metabolic Variables
Blood laboratory values were previously measured (3) and the 
values were used to calculate Pearson product moment correla-
tions with serum adiponectin, percent unmodified adiponectin, 
and FGF21 levels. Serum adiponectin was positively associated 
with FGF21 (ρ = 0.788, P < 0.001) and heptadecanoic acid C17:0 
(ρ =  0.441, P =  0.008) and negatively associated with ferritin 
(ρ = −0.425, P =  0.011), transferrin saturation (ρ = −0.381, 
P =  0.024), and iron (ρ = −0.433, P =  0.009) (Table  1). The 
amount of percent unmodified adiponectin was negatively cor-
related with total SPH (ρ = −0.434, P =  0.009) and positively 
correlated with insulin (ρ  =  0.425, P  =  0.011) and ferritin 
(ρ = 0.422, P = 0.012) (Table 1). FGF21 was negatively correlated 
with iron (ρ = −0.430, P =  0.013) (Table 1). Adiponectin and 
FGF21 were both negatively correlated with Cer 14:0, Cer 18:0, 
Cer 18:1, Cer 20:1, and Cer 22:1 (Table 1). No significant cor-
relations were observed between the levels of serum adiponectin, 
percent unmodified adiponectin, or FGF21 with total ceramides, 
glucose, triglycerides, ceruloplasmin, and haptoglobin (Table S2 
in Supplementary Material).
significant changes in ceramide levels 
Were Observed with a Modified Diet
Serum ceramide levels were measured in the six dolphins at each 
time interval (Figure 2; Table S3 in Supplementary Material). 
Ceramide 24:1 was the most abundant ceramide measured in 
FigUre 1 | The six bottlenose dolphins on a modified fish diet display an increase in total serum adiponectin and a decrease in percent unmodified 
adiponectin. Symbols and lines correspond to the measured values of (a) total adiponectin (picomole per milliliter) and (B) percent unmodified adiponectin in each 
dolphin from time 0 to week 24. (c) The mean change in total adiponectin and (D) mean percent change in percent unmodified adiponectin for the six dolphins at 
each time point over the 24-week study (n = 6; except for week 3, n = 5). Data are presented as means and error bars indicate SD. A repeated measures one-way 
ANOVA with a Holm–Sidak post hoc test was used to determine significant changes in adiponectin levels versus week 0 (*denotes P < 0.05).
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the serum of the six dolphins comprising 40% on average of the 
total ceramides measured (Table S3 in Supplementary Material). 
The levels of Cer 24:1 were significantly reduced 18% at week 6, 
24% at week 12, 33% at week 18, and 29% at week 24 compared 
to week 0 (Figure 2E). Ceramide 18:1 comprised about 2% of 
the total ceramides measured and was reduced 18% at week 3, 
21% at week 6, 24% at week 12, 39% at week 18, and 27% at week 
24 compared to week 0 (Figure 2A). Ceramide 20:1 comprised 
~1% of the total ceramides measured and was reduced 21% at 
week 3, 15% at week 6, 24% at week 12, 28% at week 18, and 
31% at week 24 compared to week 0 (Figure 2C). The Cer d16:0 
composed ~1% of the total ceramides and was significantly 
reduced ~46% at week 18 compared to week 0 (Table S3 in 
Supplementary Material). Ceramide 22:0 comprised ~7% of 
total ceramides and was significantly increased 96% at week 3, 
59% at week 6, 69% at week 12, 44% at week 18, and 50% at week 
24 compared to week 0 (Figure 2B). Ceramide 24:0 comprised 
roughly 11% of total ceramides and was significantly increased 
183% at week 3, 98% at week 6, 129% at week 12, 66% at week 
18, and 111% at week 24 compared to week 0 (Figure  2D). 
Ceramide 26:0 comprised ~1% of total ceramides and was 
significantly increased 143% at week 3, 85% at week 6, 149% 
at week 12, 71% at week 18, and 111% at week 24 compared to 
week 0 (Figure 2F). No statistically significant change in serum 
levels of Cer 14:0, Cer 16:0, Cer 18:0, Cer 20:0, Cer 22:1, and 
Cer 26:1, which comprised roughly 3, 14, 9, 3, 4, and 5% of 
total serum ceramides measured, respectively, were observed 
compared to week 0 (Table S3 in Supplementary Material).
serum sphingosine levels increased  
on a Modified Diet
Serum sphingosine levels were compared at each time point 
to week 0 (Figure  3; Table S3 in Supplementary Material). 
Dihydrosphingosine was significantly elevated by 32% at 6 weeks 
TaBle 1 | significant Pearson product moment correlations (ρ) for adiponectin, percent unmodified adiponectin, and FgF21 with ceramides and blood 
laboratory measurements.
Measured metabolic variables adiponectina (ρ) P-value % Unmodified 
adiponectina (ρ)
P-value FgF21b (ρ) P-value
Cer 14:0 −0.375 0.026 0.018 0.921 −0.457 0.008
Cer d16:0 −0.099 0.569 0.380 0.024 −0.001 0.997
Cer 18:0 −0.456 0.006 −0.439 0.008 −0.412 0.017
Cer 18:1 −0.490 0.003 0.150 0.390 −0.384 0.027
Cer 20:0 −0.276 0.108 −0.495 0.002 −0.179 0.319
Cer 20:1 −0.650 <0.001 −0.354 0.037 −0.522 0.002
Cer 22:1 −0.615 <0.001 −0.029 0.867 −0.482 0.005
dSPH −0.089 0.609 −0.404 0.016 −0.286 0.107
S1P 0.143 0.412 −0.391 0.020 −0.099 0.583
Total sphingosines 0.075 0.669 −0.434 0.009 −0.23 0.198
FGF21 0.788 <0.001 0.202 0.261 – –
Venn-Watson et al. (3) Values
Insulin 0.120 0.493 0.425 0.010 0.072 0.692
Iron −0.433 0.009 −0.053 0.763 −0.430 0.013
Transferrin saturation −0.381 0.024 −0.221 0.202 −0.344 0.050
Ferritin −0.425 0.011 0.422 0.012 −0.306 0.083
Heptadecanoic acid (C17:0) 0.441 0.008 0.161 0.357 0.218 0.223
an = 35.
bn = 33.
Significance P < 0.05 are indicated in bold.
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(180  ±  24  pmol/ml), 34% at 18  weeks (186  ±  30  pmol/ml), 
and 45% at 24 weeks (199 ± 43 pmol/ml) compared to week 0 
(140 ± 27 pmol/ml). The levels of dS1P were significantly elevated 
by 157% at week 24 (88 ±  20  pmol/ml) compared to week 0 
(35 ± 5 pmol/ml) (Figure 3B). The most abundant sphingosine 
measured was S1P that comprised ~49% of the total SPH and 
was significantly elevated by 92% at week 24 (404 ± 59 pmol/ ml) 
compared to week 0 (211 ± 13 pmol/ml) (Figure 3C). The levels 
of total SPH (sum of SPH measured) were significantly increased 
by 21% at 6 weeks, 19% at 12 weeks, 24% at 18 weeks, and 62% 
at 24  weeks after the change in diet (Figure  3D). Mean total 
ceramides were numerically lower, but were not statistically 
significant compared to time 0 (Figure 3D). The change in serum 
levels of SPH, which comprised roughly 12% of the total SPH, 
was not statistically significant compared to week 0 (Table S3 in 
Supplementary Material).
significant changes in serum Proteins 
identified by Mass spectrometry
Mass spectrometry-based proteomics of undepleted serum led to 
the identification of 59 proteins with a false discovery rate <0.1%. 
Eight proteins were significantly different over the 24-week study 
relative to time 0 (Table 2). Corroborating the PRM-MS data, adi-
ponectin was significantly elevated by 2.66-, 2.79-, and 2.99-fold 
at weeks 12, 18, and 24 compared to week 0, respectively (Table 2). 
Haptoglobin was elevated by 1.72-fold at week 12 and 1.55-fold 
at week 18, compared to week 0 (Table 2). Inter-alpha (globulin) 
inhibitor H3 displayed a 1.51-fold increase only at week 12 com-
pared to week 0 (Table 2). Serpin peptidase inhibitor, clade C-1 
(antithrombin III) was the only protein significantly reduced, but 
this reduction was transient and only reduced at week 6 (−1.50-
fold change) compared to week 0 (Table 2). Although ANOVA 
identified Hemoglobin subunit beta, hemoglobin subunit alpha, 
apolipoprotein E, and albumin as significantly different, post hoc 
analysis did not indicate statistical differences at any time point 
compared to week 0 (Table 2).
DiscUssiOn
Feeding dolphins a modified fish diet can reduce serum ferritin 
concentration within 3  weeks and normalize insulin, glucose, 
and triglycerides by 24 weeks (3). A modified diet with increased 
dietary intake of C17:0 has been proposed as a primary contribu-
tor to these effects. It was speculated that decreased ferritin, in 
part, may have led to an increase in insulin sensitivity. This 
speculation seems reasonable given that hyperferritinemia is a 
marker of insulin resistance (21) and that lowering serum fer-
ritin is known to improve insulin resistance in humans with liver 
disease (22). The link between iron and the insulin sensitizing 
adipokine, adiponectin, has also been well established (23) where 
high serum iron leads to a reduction in serum adiponectin and in 
turn decreases insulin sensitivity.
Because of the challenges in determining insulin resistance 
in dolphins, we decided to investigate hormonal changes in 
the insulin sensitizing FGF21/adiponectin/ceramide axis that 
would be consistent with improving insulin sensitivity (5). The 
insulin sensitizing hormone adiponectin increased in dolphins 
fed a modified diet over the 24-week period, which supports the 
hypothesis of increasing insulin sensitivity in dolphins fed a 
diet higher in mullet or pinfish (3). Furthermore, there was 
a positive correlation between adiponectin and serum levels 
of the fatty acid C17:0, supporting the notion that elevated 
C17:0 may be a contributor to adiponectin mediated insulin 
sensitivity. There was also an inverse correlation between adi-
ponectin and several serum iron indices; ferritin, total iron, 
and percent transferrin saturation (Table 1), suggesting that 
FigUre 2 | serum ceramide levels that significantly changed over the 24-week study in bottlenose dolphins on a modified fish diet. Ceramides  
(a) Cer 18:1, (B) Cer 20:1, (c) Cer 22:0, (D) Cer 24:0, (e) Cer 24:1, and (F) Cer 26:0 were measured by LC/MS. A repeated measures one-way ANOVA with a 
Holm–Sidak post hoc test was used to determine significant changes in individual ceramide levels versus week 0 (* denotes P < 0.05).
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iron status is related to circulating adiponectin concentration 
in dolphins, as has been reported for humans (23). At the 
population level, total adiponectin is not different between 
dolphins with elevated iron versus healthy controls (17) which 
appears to contradict these findings. However, in this study 
we considered each individual as its own control and indi-
vidual changes from baseline demonstrated a greater power to 
discover changes in adiponectin over time following intervention 
(Figure 1C).
Since high levels of serum ferritin are associated with lower 
HMW levels of adiponectin in people with type 2 diabetes 
(24), we measured percent unmodified adiponectin, which 
is considered a proxy of HMW adiponectin (17), and has 
been shown to discriminate between dolphins with high iron 
load versus healthy controls at a 2  h post-prandial time point. 
In non-diabetic humans, the post-prandial reduction in serum 
HMW adiponectin, but not total adiponectin, is considered a 
normal response (25); whereas, insulin-resistant humans do not 
exhibit a reduction in post-prandial serum HMW adiponectin. 
If insulin sensitivity was being restored in the study dolphins, 
then a reduction in percent unmodified adiponectin, i.e., HMW 
adiponectin, should be observed after feeding, like that shown for 
non-diabetic humans. As early as 3 weeks, percent unmodified 
adiponectin was reduced and remained reduced over the 24 week 
study (Figure 1D). The HMW adiponectin response to feeding 
in the study dolphins are consistent with the improved insulin 
sensitivity observed in non-diabetic humans (25). Furthermore, 
post-prandial percent unmodified adiponectin was also positively 
correlated with serum ferritin levels, indicating that improvement 
in the HMW adiponectin response could be due to lower serum 
FigUre 3 | serum sphingolipid levels and total serum ceramide levels over the 24-week study from bottlenose dolphins on a modified fish diet. 
Abundances of the sphingolipids (a) dihydrosphingosine (dSPH), (B) dihydrosphingosine 1-phosphoste (dS1P), and (c) sphingosine 1-phosphate (S1P) were 
significantly increased at week 24 compared to week 0. (D) Total sphingosines represented as the sum of dSPH, dS1P, sphingosine, and S1P were increased 
compared to week 0, whereas total ceramides represented as the sum of ceramides listed in Table S2 in Supplementary Material were not significantly different.  
A repeated measures one-way ANOVA with a Holm–Sidak post hoc test was used to determine significant changes in individual sphingosine levels versus week 0  
(* denotes P < 0.05). Data are reported as mean ± SD.
TaBle 2 | changes in quantitative spectral counts normalized to total Tic for proteins identified in the serum of the 24-week feeding study dolphins 
that were significantly different over time.
identified proteins ensemble iD rM-anOVa 
(P < 0.05)
Fold change from week 0
0 versus 6 0 versus 12 0 versus 18 0 versus 24
SERPINC1 (antithrombin) ENSTTRP00000008123 0.033 −1.50* −1.07 1.08 −1.22
Hemoglobin subunit beta ENSTTRP00000016564 0.03 −1.34 1.84 1.58 1.17
Haptoglobin ENSTTRP00000001793 0.041 1.02 1.72* 1.55* 1.02
Hemoglobin subunit alpha ENSTTRP00000011461 0.048 −1.29 1.89 1.63 1.14
Apolipoprotein E ENSTTRP00000008256 0.041 −1.59 1.15 1.21 1.28
Adiponectin ENSTTRP00000015964 0.001 1.93 2.66* 2.79* 2.99*
Albumin ENSTTRP00000006225 0.049 1.02 −1.03 −1.01 1.02
Inter-α (globulin) inhibitor H3 ENSTTRP00000002122 0.021 −1.73 1.51* 1.24 1.33
*P < 0.05 for indicates a significant fold change using Holm–Sidak Post hoc test for multiple comparisons to control (week 0).
Fold change was calculated using non-transformed means.
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ferritin or vice versa. We propose that the reduction in percent 
unmodified adiponectin in dolphins represents a picture similar 
to non-diabetic humans that supports the contention that insulin 
sensitivity is being restored in dolphins fed a modified diet that 
included increased C17:0 intake.
FgF21–adiponectin–ceramide axis
FGF21 expression has been shown to elicit a multitude of 
beneficial metabolic responses ranging from reducing blood 
glucose, improving lipid utilization, and elevating insulin sen-
sitivity (26, 27). Many of the beneficial effects of FGF21 have 
been ascribed to its ability to induce adiponectin and lead to 
the sequential reduction in serum ceramides, also known as 
the FGF21/adiponectin/ceramide axis (5). Overexpression of 
FGF21 increases adiponectin and reduces ceramides in the 
serum of rodents, but is ineffective at lowering blood glucose 
and ceramide levels in adiponectin knockout mice (5, 28). To 
determine whether the elevation in total adiponectin in dolphins 
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on a C17:0-rich diet was preceded by an increase in FGF21, we 
utilized a commercial ELISA previously used to measure serum 
FGF21 in cattle (29, 30). The serum FGF21 concentrations were 
highly variable among this study’s dolphin population (129–
1599 pg/ml), but was within similar ranges reported for humans 
21–5300 pg/ml (31), pregnant cows 15–1600 pg/ml (29), pigs 
225–325 pg/ml (32), northern elephant seals ~100–500 pg/ml 
(33), and rhesus monkeys 10–325 pg/ml (34). Even though we 
observed no significant difference between FGF21 levels over 
time, FGF21 was highly correlated with the abundance of total 
adiponectin (Table 1). The tight correlation with adiponectin 
levels suggest that both hormones are linked, and the lack of 
changes in FGF21 concentration over time may be explained 
by its dynamic nature. In humans, post-prandial FGF21 levels 
decrease in a similar manner to HMW adiponectin with the 
highest relative reduction being greatest in healthy individuals 
(35, 36). As a consequence of not having fasted FGF21 levels, 
we are unable to determine if the relative reduction in 2  h 
post-prandial FGF21 levels improve on the diet. Given the tight 
correlation with adiponectin, it is possible that the FGF21/
adiponectin axis is functional in dolphins. However, the lack 
of a clear elevation in FGF21 levels over the feeding study does 
not allow us to conclude that FGF21 plays a direct role in the 
elevation of adiponectin. A more intensive sampling regime at 
both fasting and post-prandial time points for each dolphin is 
required to test whether changes in FGF21 precedes changes in 
adiponectin.
The third arm of the FGF21 axis includes ceramides and SPH. 
Total serum ceramide levels are elevated in diabetic animals 
(37, 38) and humans, along with reduced total serum SPH (39). 
Activation of adiponectin receptors leads to the downstream 
activation of ceramidase that converts ceramides into SPH 
resulting in increased systemic levels of the pro-survival S1P 
(11). The increase in S1P likely conveys the pro-survival effects 
that adiponectin has demonstrated on pancreatic beta cells 
(40), as well as its preventative role in podocyte injury (41) 
and liver regeneration (42). The balance between ceramides to 
S1P in dolphins had not been previously described; however, 
our results support a role for adiponectin in this balancing 
act driving the scale toward S1P-mediated insulin sensitivity. 
Consistent with the FGF21/Adiponectin/ceramide axis (5), 
total serum sphingosine was elevated over time implicating 
an increase in ceramidase activity. The major dolphin serum 
ceramide (Cer 24:1, Figure S3 in Supplementary Material) 
was significantly reduced at 6  weeks and remained depressed 
through 24  weeks, even though total serum ceramides were 
not significantly decreased as would be expected if adiponectin 
was acting through ceramidase. Interestingly, Cer 24:1 did not 
inversely correlate with total adiponectin, but may be relevant to 
metabolic syndrome as it is one of the most elevated ceramides 
in the plasma of female children with type 2 diabetes (43). Of 
note, the unsaturated ceramides Cer 24:1, 20:1, and 18:1 were 
all reduced from 6 to 24 weeks, whereas the saturated ceramides 
Cer 26:0, 24:0, 22:0 were all elevated from 3 to 24 weeks. This 
result may be explained by the fact that unsaturated ceramides 
are the preferred substrate for alkaline ceramidases, which 
is preferentially enhanced upon stimulation of adiponectin 
receptors (11, 44). Feeding may also underlie some of these 
differences, in that, saturated ceramides Cer 20:0, Cer 18:0, and 
Cer 16:0 are higher in non-fasted humans compared to fasted 
humans (45), whereas fewer unsaturated ceramides were found 
to change with fasting. Because dolphins differ from humans in 
both total ceramides and ceramide composition (Figures S3 and 
S4 in Supplementary Material), it is difficult to extend findings 
of individual ceramide species in dolphins to specific clinical 
diseases in humans. However, the changes in the major cera-
mide species and total SPH are in agreement with that predicted 
if insulin sensitivity was being restored.
Proteomics results
To investigate whether changes in non-targeted serum proteins 
were being affected by dietary change, a cursory proteomic anal-
ysis of serum digests was conducted. Of the 59 high abundance 
proteins identified, eight proteins were considered statistically 
different. Adiponectin was found to be elevated at weeks 12–24, 
consistent with the targeted mass spectrometry assay data. 
Aside from adiponectin, only one other protein was elevated at 
more than one time point. Haptoglobin was elevated at weeks 12 
and 18 and follows a pattern of abundance similar to that of the 
hemoglobin subunits. Haptoglobin binds to free hemoglobin to 
facilitate its removal from blood, which prevents the oxidative 
damage due to iron (46). Obese rats supplemented with n-3 
polyunsaturated fatty acids showed a significant increase in 
post-prandial haptoglobin compared to control diet animals, 
although a mechanism underlying this elevation was not stated 
(47). The transient changes in serum haptoglobin could imply 
a small transient acute phase pro-inflammatory response, but 
this result could also be simply ascribed to different levels of 
hemolysis during the blood draw. Differences in haptoglobin 
levels were not previously observed for this study population 
determined by a standardized assay (3). Overall, changes in 
high abundance serum proteins were largely absent aside from 
adiponectin.
limitations
Because we were unable to obtain 2-h post-prandial serum samples 
from dolphins on a standard diet, we cannot determine whether 
or not the response in serum adiponectin, ceramides, or SPH are 
due to season. For example, managed spinner dolphins (Stenella 
longirostris) exhibit seasonal variations in testosterone concentra-
tion (48). Seasonal changes in blood chemistry values and the 
skin transcriptome have also been documented in bottlenose 
dolphins (49, 50). Although not overwhelmingly correlated, sex 
hormones have been weakly correlated with adiponectin levels in 
humans (51, 52). As a result, the fluctuation in adiponectin levels 
could be affected by seasonal changes over the 24-week period 
collected for this study. Therefore, caution should be taken when 
ascribing effects due to the modified diet alone. Lastly, the use of 
a pan-mammalian ELISA to measure FGF21 concentrations has 
not been validated for dolphin FGF21. The lack of a recombinant 
standard dolphin FGF21 protein did not allow for calculations of 
cross-reactivity.
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cOnclUsiOn
These data provide indirect support of improved insulin sensitiv-
ity in dolphins fed a modified diet, which included increased 
C17:0 intake, based on increasing adiponectin serum concentra-
tion and SPH. With the exception of FGF21, our data support the 
hypothesis that dietary intervention in dolphins leads to an eleva-
tion in total adiponectin, an elevation in total sphingosine, and 
a reduction in the major ceramide species (Cer 24:1). Significant 
correlations between serum iron, serum ferritin, FGF21, and 
adiponectin suggest that the FGF21/adiponectin/ceramide axis 
is a regulatory hormonal axis in dolphins.
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